Loading...
OTCM
WPHM
Market cap0USD
Apr 29, Last price  
0.00USD
Name

Winston Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:WPHM chart
P/E
0.00
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
1m
+208.17%
000452,5421,394,587
Net income
-3m
L-48.36%
-230,800-464,995-180,105-5,141,746-2,655,316
CFO
-4m
L+37.11%
-37,270-105,764-172,990-3,062,220-4,198,636

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis. They also tackle pain and inflammation linked to inflammatory bowel disease, alongside other specialized therapeutic areas. The organization, initially established as Winston Laboratories, Inc., adopted its present name, Winston Pharmaceuticals, Inc., in November 2008. Founded in 1998, Winston Pharmaceuticals maintains its principal operations in Vernon Hills, Illinois.
IPO date
Feb 23, 2006
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show